Keywords: boeh, ingelheim/novo, nordisk, anti-obesity, collaboration, germany, boehringer

Boeh Ingelheim/Novo Nordisk Anti-Obesity Collaboration

Article | 18 November 1996

Print This

Germany's Boehringer Ingelheim and Danish firm Novo Nordisk have entered into a multi-year agreement on research into drug treatment for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in